Boston University scientists developed an AI model that predicts Alzheimer's-related protein levels using brain imaging and clinical data.
Key Details
- 1AI tool predicts presence of amyloid beta and tau proteins linked to Alzheimer's disease.
- 2Model incorporates brain scans, cognitive scores, genetics, and health history from 12,185 participants across seven cohorts.
- 3Tool provides location-specific brain information, unlike most blood tests.
- 4Successfully validated on a separate international cohort, showing robust predictive performance.
- 5Aims to enable earlier, cheaper, and more accessible Alzheimer's detection and staging.
- 6Published in Nature Communications on August 11, 2025.
Why It Matters
Accurate, cost-effective early detection of Alzheimer's using non-invasive imaging and AI could transform patient care and expedite selection for clinical trials. This approach highlights the expanding role of imaging AI in neurological disease diagnosis and management.
Source
EurekAlert
Related News
•EurekAlert
BraDiPho: New 3D AI Atlas Integrates Brain Dissections with MRI
Researchers have developed BraDiPho, a tool that merges ex-vivo photogrammetric brain dissection data with in-vivo MRI tractography using AI.
•EurekAlert
AI Maps Genetic Factors Shaping the Corpus Callosum via MRI Scans
USC researchers used AI to analyze MRI scans and uncover the genetic architecture of the brain's corpus callosum.
•EurekAlert
WashU Launches AI Imaging Center to Advance Precision Diagnostics
Washington University establishes a new center to develop AI-powered imaging tools for better diagnosis and precision medicine.